These three biotech stocks are undervalued: Wedbush analyst - BNN Bloomberg

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 50%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

Biotech stocks have underperformed the S&P 500 over the past year but one investment expert remains bullish on the space.

Andreas Argyrides, vice president of equity research at Wedbush Securities, told BNN Bloomberg on Tuesday that while a high interest rate environment tends to weigh on the biotech sector, there are several companies currently being overlooked by investors.He called this a “good stock environment” for the industry, and said he looks at late-stage companies with strong financial assets, good balance sheets and good prospects for future revenue growth.

The world economy has lost momentum from the impact of higher interest rates, the invasion of Ukraine and widening geopolitical rifts, and it now faces new uncertainty from the war between Israel and Hamas militants, International Monetary Fund warned Tuesday.Workers at General Motors Co.’s Canadian plants are on strike, idling key factories in Ontario, after contract negotiations with the union representing about 4,300 employees failed to bring an agreement.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in FİNANCE

Finance Finance Latest News, Finance Finance Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stock Market Can’t Ignore Impact of Rates on Earnings This Season - BNN BloombergStock markets that have refused to buckle under the highest yields since 2007 face a new test. Third-quarter results will shine a light on how much those rates are already hitting profits — and what they’ll do to lofty equity valuations.
Source: BNNBloomberg - 🏆 83. / 50 Read more »